Lou Allegretto

Lou Allegretto is an accomplished executive with extensive experience in the pharmaceutical industry, currently serving as VP of US Commercial Strategy, Insights, Transformation & Operations at GSK since November 2019, while also leading the US Specialty Marketing for Immunology, Respiratory, and Hepatology portfolios. Prior to GSK, Lou held various senior leadership roles at The Janssen Pharmaceutical Companies of Johnson & Johnson from November 1998 to November 2019, including U.S. Brand Lead for Ovarian Cancer and Hematology Marketing, and Sr. Director of Global Commercial Strategy for Apalutamide in prostate cancer. Lou's career at Johnson & Johnson included significant contributions to oncology product strategies such as IMBRUVICA and PROCRIT. Lou holds an MBA in Marketing and Finance from NYU Stern School of Business and a BS in Biology from Rutgers University.